Treace Medical Concepts, Inc.
TMCI
$6.52
-$0.205-3.05%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 14.75% | 92.02% | 12.33% | -72.81% | -38.81% |
| Total Depreciation and Amortization | 28.92% | -2.52% | 37.92% | 93.24% | 106.60% |
| Total Amortization of Deferred Charges | -1.33% | 87.28% | -1.33% | 0.00% | 1.35% |
| Total Other Non-Cash Items | 24.85% | 69.50% | 30.40% | 131.12% | 160.67% |
| Change in Net Operating Assets | 394.80% | -1,022.16% | -868.25% | -240.29% | 119.86% |
| Cash from Operations | 158.14% | -890.79% | -24.48% | -66.73% | 58.16% |
| Capital Expenditure | 9.78% | -36.74% | 18.22% | 59.13% | -165.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -78.54% | -10.48% | 6.52% | 74.99% | 109.73% |
| Cash from Investing | -150.40% | -31.68% | 25.36% | 315.23% | 104.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 128.85% | -67.98% | -99.90% | -- | -99.95% |
| Repurchase of Common Stock | -69.20% | -138.46% | -- | 100.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -52.43% | -84.24% | -94.97% | -73.64% | -100.17% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 155.43% | -113.32% | -27.62% | 150.33% | -135.98% |